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Introduction
Neuroblastoma is the most common pediatric extracranial 
solid tumor derived from primitive neural crest cells of the 
sympathetic nervous system [1,2]. Of all neuroblastomas, 
75% arises in the abdomen, 20% in the thorax, and 5% 
in the neck. Primary tumors can occur anywhere along the 
sympathetic chain from the neck to the pelvis [2]. The clinical 
manifestations depend on the primary location of the tumor 
and the extent of metastatic disease [2,3]. Although neuro-
blastoma is a common tumor in the perinatal period, few cas-
es of fetal thoracic neuroblastoma have been reported [4-6]. 
Thoracic neuroblastoma often causes respiratory difficulties in 
neonatal period and the treatment options for neuroblastoma 
includes surgical resection with or without adjuvant chemo-
therapy due to its metastatic property, so it is important to 
detect fetal thoracic neuroblastoma prenatally [1-3]. Hence, 
we are reporting this case to share an experience of prenatal 
detection of thoracic neuroblastoma.
Case report
A 33-year-old second-gravida was referred to a tertiary care 
center at 30 weeks of gestation for evaluation of a right lung 
mass in the fetus. The mother had no significant complication 
in her previous pregnancy and no other antenatal problem 
was reported in this pregnancy before 30 weeks of gesta-
tion. A 32×31 mm, well-defined calcified hyperechoic mass 
in the right thorax with hypoechogenic right pleural effusion 
was detected on antenatal ultrasonography at our hospital, 
which was initially suspected to be a teratoma (Fig. 1A). The 
fetal thoracic mass increased in size up to 39×32 mm and the 
amount of right pleural effusion increased during 3 weeks 
of evaluation (Fig. 1B). Fetal hydrops including 7 mm deep 
ascites and generalized subcutaneous edema developed at 
33 weeks of gestation (Fig. 1C). No other significant defect 
in fetal structure was found. Fetal surveillance tests, includ-
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ing biophysical profiling and non-stress test were conducted. 
Minimal variability was noted on the non-stress test.
A male baby weighing 2,780 g was delivered through an 
emergency cesarean section owing to non-reassuring fetal 
heart beat patterns, and admitted to the neonatal intensive 
care unit with Apgar score 3 at 1 minute and 5 at 5 minutes. 
No metastatic lesion was found in the placenta and umbilical 
cord. Initial neonatal hemoglobin from arterial blood was 12.6 
g/dL, neonatal hemoglobin dropped to 9.4 g/dL after thora-
centesis. Initial neonatal red cell distribution width was slightly 
increased (18.9%), which suggests fetal anemia was due to 
the hemorrhage of the tumor. Bone marrow biopsy revealed 
no metastasis to bone marrow.
Contrast-enhanced computed tomography of the chest re-
vealed a 40×40×30 mm enhanced tumor in the right thorax 
with bilateral hemothorax causing mediastinal shifting to the 
left, which was considered a posterior mediastinal teratoma 
or neurogenic tumor (Fig. 2A). Moreover, multiple hepatic 
metastases were suspected on magnetic resonance imaging 
(Fig. 2B) and abdominal ultrasonography. The neuro-specific 
enolase (NSE) level was 78.7 ng/mL. At 7 days after delivery, 
neuroblastoma was diagnosed on excision biopsy of the right 
thoracic lesion followed by surgical excision of the thoracic 
mass, which revealed massive hemothorax. A diagnosis of a 
Fig. 1. (A) An irregularly shaped hyperechoic solid mass with cal-
cification was detected in the transabdominal sonographic image 
of the sagittal section of the right thorax of the fetus at 30 weeks 
of gestation. (B) The irregularly shaped hyperechoic solid mass 
increased in size compared with the previous examination, with 
massive hydrothorax at 33 weeks of gestation. (C) Ascites in the 
abdominal cavity was found around the fetal liver, with subcuta-
neous edema of the abdominal wall, and these were considered 
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primary thoracic neuroblastoma with liver metastasis was con-
firmed and no amplification of N-myc proto-oncogene (MYCN) 
was detected. 
The patient completed 8 courses of chemotherapy admin-
istered every 3 weeks. NSE was monitored as a marker of 
disease progression. No evidence of local recurrence or me-
tastasis was found on the magnetic resonance image after 6 
months of chemotherapy. This patient developed normally.
Discussion
Most space-occupying lesions discovered in the thoracic cavity 
during prenatal ultrasound are bronchopulmonary malforma-
tions (BPMs). Congenital cystic adenomatoid malformation 
and pulmonary sequestration represent >85% of BPMs. These 
congenital malformations are usually intraparenchymal, with 
cystic, solid or mixed (cystic and solid) form. The main differ-
ential diagnosis of BPM is diaphragmatic hernia [7].
True thoracic neoplasms often develop within the medias-
tinum. Lymphangioma is one of most common mediastinal 
tumors, and it rapidly develops within the anterior mediasti-
num. An enlarged mass can lead to fetal hydrops and polyhy-
dramnios. Another common mediastinal tumor is a teratoma, 
which can be calcified and contain hemorrhagic areas [7-9]. 
Furthermore, neuroblastoma is another condition that could 
occur in the posterior mediastinum.
Although thoracic neuroblastomas account for a minority of 
all neuroblastoma cases (11%–26%), they remain the most 
common mediastinal mass in patients aged <2 years [10]. 
Thoracic neuroblastoma has a relatively favorable prognosis 
and is generally associated with better outcomes than neu-
roblastomas arising in other areas. Although the mechanism 
for the more favorable prognosis is unclear, it is known that 
thoracic neuroblastomas tend to be detected at an earlier 
age and present with a higher frequency of localization at the 
time of diagnosis than non-thoracic neuroblastomas [10,11].
The reported clinical manifestation of thoracic neuroblas-
tomas is severe respiratory distress due to tracheal compres-
sion by the tumor. However, this does not apply to fetuses 
because fetuses in the uterus do not need to breathe through 
their respiratory system. As Moppett et al. [12] had reported 
in 1999, 2 of 33 cases of neuroblastomas from their cases 
and reviewed literature originated from the thorax without 
prenatal ultrasound detection. Those thoracic neuroblastomas 
were incidentally diagnosed after respiratory distress occurred 
in the neonatal period. Although the patients survived after 
thoracotomy, they had comorbidities with complications such 
as abnormal sweating and flaccid paralysis of the lower limbs 
[4,12]. In 10 of 134 (7.5%) newborns in the Italian registry, 
neuroblastomas arose from the thorax and only 20% of neuro-
blastomas regardless of location were prenatally detected [6].
Fig. 2. (A) Postnatal evaluation with chest computed tomography showed a highly attenuated mass with calcification and massive hydro-
thorax. (B) Neonatal magnetic resonance imaging of the liver showed multiple nodules with low signal intensity (arrows) in both lobes of 
the liver, suggesting multiple hepatic metastasis.
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Fetal hydrops is a comorbidity of fetal neuroblastomas 
[12,13]. Hydrops associated with a neuroblastoma could be 
due to anemia from bone marrow replacement or hemor-
rhage from the tumor. Other proposed causes are the com-
pression of the vena cava leading to the obstruction of venous 
return from neoplastic hepatomegaly, or a large tumor [14,15].
Most of the previously reported thoracic neuroblastomas 
were diagnosed in the perinatal period due to neonatal 
respiratory distress. This case adds an additional value as it 
was detected prenatally even before the onset of neonatal 
distress. Also, this case includes 15 months follow up of the 
clinical course.
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